A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Abroad (travel likely)RecruitingPHASE2
Conditions
HIV-1-infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Midway Immunology and Research Center, Ft. Pierce, Florida, United States
North Texas Infectious Disease Consultants, P.A., Dallas, Texas, United States
Diagnostic Clinic of Longview, Longview, Texas, United States
Study leads
Gilead Study Director
Study Director
Gilead Sciences